• S10E7: A conversation with Recordati's Dr. Mario Maldonado

  • Jul 11 2024
  • Durée: 39 min
  • Podcast

S10E7: A conversation with Recordati's Dr. Mario Maldonado

  • Résumé

  • Today's podcast features my chat with Dr. Mario Maldonado, Head of Development and Global Endocrinology atRecordati Rare Diseases. Dr. Maldonado brings a wealth of experience and a great perspective on drug development. He was involved in developing both pasireotide and osilodrostat, two essential compounds used in drugs to treat Cushing's. Listen to this fascinating talk with one of the most dynamic experts in endocrine drug development today. He talks about endocrinology, the science of cortisol production, the art and science of endocrine medicine, and the opportunities for new drugs and therapies in the US and Europe. We also focused on the findings from a Recordati new study, LINC-7, - read more about the study here - potentially leading to new indications (uses) for osilodrostat (Isturisa®).

    Click here for more information and content on Cushing's and hypercortisolism from Pituitary World News.

    Now available, Dr. Lewis Blevins new book "Cushing's; a comprehensive guide to understanding a devastating disease". Click here to buy your copy today or click on the book graphic below.

    Voir plus Voir moins

Ce que les auditeurs disent de S10E7: A conversation with Recordati's Dr. Mario Maldonado

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.